Metraipolis › archive › dc_35cbe0591b3a

Anti-VEGF immunotherapy with HEBERSaVax suppresses melanoma growth and metastasis via angiogenesis blockade and enhanced T-cell infiltration — Europe PMC PMID:41488668

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41488668
DOI
10.3389/fimmu.2025.1667651
License (as archived)
solo-consultazione
Archived
2026-11-07T12:51:27.581Z
SHA-256 of the archived text
e8e7d78d9f2151dcd0f3d4e36fc98a9b9dcc99cee0cbc22c32f46ef8027fe487
Stable URL of this page
https://metraipolis.com/documento/dc_35cbe0591b3a

How to cite

Anti-VEGF immunotherapy with HEBERSaVax suppresses melanoma growth and metastasis via angiogenesis blockade and enhanced T-cell infiltration — Europe PMC PMID:41488668 — Europe PMC (en), https://europepmc.org/article/MED/41488668 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_35cbe0591b3a (Metraipolis archive dc_35cbe0591b3a, sha256 e8e7d78d9f2151dcd0f3d4e36fc98a9b9dcc99cee0cbc22c32f46ef8027fe487)
BibTeX
@misc{dc35cbe0591b3a,
  title = {Anti-VEGF immunotherapy with HEBERSaVax suppresses melanoma growth and metastasis via angiogenesis blockade and enhanced T-cell infiltration — Europe PMC PMID:41488668},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41488668},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_35cbe0591b3a; sha256 e8e7d78d9f2151dcd0f3d4e36fc98a9b9dcc99cee0cbc22c32f46ef8027fe487},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488668. Agents can read the archived copy with the MCP tool read_document.